Palo Alto, CA, United States of America

Nahid S Waleh


Average Co-Inventor Count = 3.2

ph-index = 5

Forward Citations = 111(Granted Patents)


Company Filing History:


Years Active: 1990-2009

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovator Nahid S Waleh: Pioneering Research in Chemotherapy and Inflammatory Diseases

Introduction

Nahid S Waleh is a prominent inventor based in Palo Alto, CA (US). She has made significant contributions to the fields of chemotherapy and inflammatory disease treatment. With a total of 6 patents, her work focuses on innovative compounds and methods that have the potential to improve patient outcomes.

Latest Patents

Among her latest patents, Waleh has developed compounds that utilize flavanoids as chemotherapeutic, chemopreventive, and antiangiogenic agents. These compounds include flavanones, flavanols, and chalcones, which are designed to inhibit cancer progression. Additionally, she has created methods for effectively inhibiting inflammatory diseases, such as Crohn's disease and ulcerative colitis. Her inventions also encompass pharmaceutical compositions and methods of synthesis and use.

Career Highlights

Waleh has worked with notable organizations, including SRI International, where she has contributed to groundbreaking research. Her innovative approaches have garnered attention in the scientific community, leading to advancements in therapeutic strategies.

Collaborations

Throughout her career, Waleh has collaborated with esteemed colleagues, including Charles K Hiebert and Keith R Laderoute. These partnerships have facilitated the exchange of ideas and fostered advancements in her research endeavors.

Conclusion

Nahid S Waleh's contributions to the fields of chemotherapy and inflammatory disease treatment highlight her role as a leading innovator. Her patents and research continue to pave the way for new therapeutic options, demonstrating her commitment to improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…